Prediction of IDH mutation status of glioma based on terahertz spectral data

Zhiyan Sun(Tongji University), Rui Tao(Capital Medical University), Xianhao Wu(University of Science and Technology Beijing), Pei Yang(Capital Medical University), Tianyao Zhang(Beijing Information Science & Technology University), Xing Liu(Capital Medical University), Zhaohui Zhang(Beijing Information Science & Technology University), Shaowen Zheng(Capital Medical University), Xiaoyan Zhao(University of Science and Technology Beijing), Jiangfei Wang(Capital Medical University), Haibin Wan(Capital Medical University)
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
March 16, 2023
10.1016/j.saa.2023.122629
Cited by 16

Related Papers

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
|NeuroImage Clinical|2018|262
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature
|European Radiology|2018|122
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
|Advanced Science|2019|106
IDH mutation-specific radiomic signature in lower-grade gliomas
|Aging|2019|50
The role of the kynurenine pathway in cardiovascular disease
|Frontiers in Cardiovascular Medicine|2024|46